Based on the expression of hormonal receptors (HR) (including estrogen and progesterone receptors, ER and PR) and human epidermal growth factor receptor 2 (HER2), BC can be classified into four subgroups: luminal A, luminal B, HER2 overexpression, and triple-negative breast cancer [8]. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.